<?xml version='1.0' encoding='UTF-8'?><xml><records><record><source-app name="HighWire" version="7.x">Drupal-HighWire</source-app><ref-type name="Journal Article">17</ref-type><contributors><authors><author><style face="normal" font="default" size="100%">Rizzo, Toni</style></author></authors><secondary-authors><author><style face="normal" font="default" size="100%">Savage, Edward B.</style></author></secondary-authors></contributors><titles><title><style face="normal" font="default" size="100%">Tricuspid Valve Disease: Unrecognized? Undertreated?</style></title><secondary-title><style face="normal" font="default" size="100%">MD Conference Express</style></secondary-title></titles><dates><year><style  face="normal" font="default" size="100%">2012</style></year><pub-dates><date><style  face="normal" font="default" size="100%">2012-09-01 00:00:00</style></date></pub-dates></dates><pages><style  face="normal" font="default" size="100%">30-31</style></pages><abstract><style  face="normal" font="default" size="100%">This article discusses the impact and management of tricuspid valve disease. Although much attention in clinical practice and research on patients with valvular heart disease has focused on disorders of the mitral and aortic valves, tricuspid regurgitation can also be associated with significant morbidity and mortality.</style></abstract><number><style face="normal" font="default" size="100%">12</style></number><volume><style face="normal" font="default" size="100%">12</style></volume></record></records></xml>